Four cases with metastatic spread to bones and with primary site unknown are reported. The histopathologic examination on the bone biopsy material in 3 cases was adenocarcinoma. One case was suspected radiologically as primary bone tumor. The usefulness of estimation of serum thyroglobulin for detection of involved primary site is discussed.
Get full access to this article
View all access options for this article.
References
1.
Lo GerfoP., StillmanT., ColacchioD.: Serum thyroglobulin and recurrent thyroid cancer.Lancet, 1: 881–882, 1977.
2.
RobbinsJ., RallJ.E., RawaonR.W.: A new serum iodide component in patients with functional carcinoma of thyroid.J. Clin. Endocrinol. Metab., 15: 1315–1331, 1955.
3.
ShahD., DandekarS., GanatraR.: Thyroglobulin levels in serum and saliva of patients with differentiated thyroid carcinoma.Proc. Soc. Indian Acad. Sci., 87B: 169–175, 1978.
4.
ShahD., DandekarS.R., JeevenramR.K., Ajaykumar, SharmaS.M., GanatraR.D.: Serum thyroglobulin in differentiated thyroid carcinoma: Histological and metastatic classification.Acta Endocrinol., 98: 222–226, 1981.
5.
SchlossbergA.H., JacobsonJ.C., IbbertsonH.K.: Serum thyroglobulin in the diagnosis and management of thyroid carcinoma.Clin. Endocrinol., 10: 17–27, 1979.
6.
Van HerleA.J., UlierR.P., MathewsN.L., BrownJ.: Radioimmunoassay for measurement of thyroglobulin in human serum.J. Clin. Invest., 52: 1320–1327, 1973.
7.
Van HerleA.J., UlierR.P.: Elevated serum thyroglobulin: A marker of metastases in differentiated thyroid carcinoma.J. Clin. Invest., 56: 272–277, 1975.
